CD44-v6 concentrations in carcinoma of the uterine cervix: Lack of prognostic significance

Archives of Gynecology and Obstetrics

Volumn 273, Issue 2, 2005, Pages 104-106

  Horn, L C ^a   Raptis, G ^a   Fischer, U ^a   Hentschel, B ^a   Kohler U ^a   Richter, C E ^a   Martin, R ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

CD 44v6; Cervical carcinoma; ELISA; Prognosis; Uterine

Indexed keywords

CD44V6 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; PROGNOSIS; TISSUE LEVEL; UTERINE CERVIX CANCER;

ANTIGENS, CD44; CELL ADHESION; FEMALE; GLYCOPROTEINS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; UTERINE CERVICAL NEOPLASMS;

EID: 29144456002     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-005-0039-5     Document Type: Article

References (15)

1. Ayhan A, Baykal C, Al A, Ayhan A (2001) Altered CD 44 variant 6 expression in FIGO IB cervical carcinoma. Gynecol Oncol 83:569-574
2. Biesold C, Köhler U, Horn LC et al (1995) CD 44 exon v6 as a predictor of lymphatic metastases in cervical carcinoma - an immunocytochemical study of 94 cases. Arch Gynecol Obstet 256:147-153
3. Callagy G, O'Grady A, Butler D et al (2000) Expression of CD 44 in uterine squamous neoplasia: a predictor for microinvasion ? Gynecol Oncol 76:73-79
4. Dall P, Hekele A, Ikenberg H et al (1996) Increasing incidence of CD 44-v7/8 epitope expression during uterine cervical carcinogenesis. Int J Cancer (Pred Oncol) 69:79-85
5. Faleiro-Rodrigues C, Lopes C (2004) E-Cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study. Pathobiology 71:329-336
6. Günthert U (1996) CD 44 in malignant disorders. Curr Top Microbiol Immunol 213:271-285
7. Harima Y, Togashi A, Horikoshi K et al (2004) Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys 60:237-248
8. Haynes BF, Liao HX, Patton KL (1991) The transmembrane hyaluronate receptor (CD 44): multiple functions, multiple forms. Cancer Cells 3:347-350
9. Horn LC, Fischer U, Bilek K (2001) Pathologic-anatomic description and basic morphological information in the management of dysplasias and carcinomas of the cervix uteri. Zentralbl Gynakol 123:255-265
10. Kainz C, Kohlberger P, Tempfer C et al (1995) Prognostic value of CD 44 splice variants in human stage III cervical cancer. Eur J Cancer 31A:1706-1709
11. Maltzmann JS, Carmen JA, Monroe JG (1996) Transcriptional regulation of the Icam-1 gene in antigen receptor- and phorbole ester-stimulated B lymphocytes: role for the transcription factor EGR 1. J Exp Med 183:1747-1759
12. Recio JA, Merlino G (2003) Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD 44-v6 in melanoma cells through Egr-1. Cancer Res 63:1576-1582
13. Speiser P, Wanner C, Tempfer C et al (1997) CD 44 is an independent prognostic factor in early-stage cervical cancer. Int J Cancer 74:185-188
14. Wells M, Östör AG, Crum CP, Franceschi S, Tommasino M, Nesland JM, Goodman AK, Sankaranayanan R, Hanselaar AG, Albores-Saavedra J (2003) Epithelial tumors of the uterine cervix. In: Tavassoli FA, Devilee P (eds) Pathology and genetics of tumours of the breast and female genital organs. World Health Organization Classifocation of Tumours. IARC Press, Lyon, pp 259-279
15. Wobus M, Kuns R, Wolf C, Horn LC et al (2001) CD 44 mediates constitutive type I receptor signaling in cervical carcinoma cells. Gynecol Oncol 83:227-234